This clinical decision-support tool helps healthcare professionals categorize lung nodules and determine follow-up actions based on ACR Lung-RADS v2022 guidelines. It offers step-by-step guidance, real-time score updates, and integration of incidental findings for consistent application of recommendations.
8.2
December 1, 2025
Version 8.2 • Added new self-assessment quiz pack Version 8.1.2 • UI/UX refinements (optimized for iOS 26) Version 8.1.1 • General improvements (e.g. enhanced support for smaller devices) Version 8.1 • Added Brock (full model) calculator • Added FAQ section Version 8.0.1 • Minor performance and stability improvements ***Version 8.0*** v8.0 is our first major update in six years, bringing Lung Cancer Screening Guide up to Lung-RADS v2022 standards. To support ongoing maintenance, regular guideline updates, and self-assessment question packs, this release introduces a free trial—after which continued use requires a 6- or 12-month auto-renewing plan. Guideline Upgrades • Upgraded from ACR Lung-RADS v1.1 to ACR Lung-RADS v2022, ensuring you have the latest criteria for lung cancer screening. Added ‘S’ modifier integration for clinically significant incidental findings—instantly flag and address other notable abnormalities. Smarter Decision Support • Expert‑curated self‑assessment question packs. Complete rebuild • Re‑engineered from the ground up for smoother interaction and greater reliability. Brand‑new modern interface optimized for both iPhone and iPad. Full Dark Mode and Dynamic Type support for comfortable viewing in any environment. Pricing update • After the free trial, continued use requires a 6‑ or 12‑month auto‑renewing subscription. Manage or cancel anytime in Settings ▸ Apple ID ▸ Subscriptions. Thanks for choosing Lung Cancer Screening Guide— a quick rating in the App Store helps us a lot!
MoreBilled every 12 months
👀
👀
Request granted!
The Lung Cancer Screening Guide is a clinical decision-support tool designed to help healthcare professionals categorize lung nodules and manage follow-up actions according to the ACR Lung-RADS v2022 guidelines. It provides step-by-step guidance and integrates incidental findings for consistent application of recommendations.
The app provides full in-app access to all Lung-RADS categories (0-4X) and the 'S' modifier, offering concise management instructions directly from the guidelines. It helps streamline the classification of lung nodules based on morphology, size, and growth.
Yes, all guideline logic runs on-device, meaning the app can be used offline without needing a login or server connection. This ensures accessibility in various clinical environments.
The app offers 6-month and 12-month auto-renewing subscriptions, with prices displayed in-app and potentially varying by region. A free trial is available for both subscription durations.
The developers strive to incorporate updates to ACR Lung-RADS or S Modifier guidance within 30 days of publication. New self-assessment question packs are planned every six months, though future additions and update frequency may change.
The app has an age rating of 12+ and is intended for medical professionals. It is a clinical decision-support tool and not a substitute for professional medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions.
The Brock (Full Model) Calculator is a feature within the app that allows users to calculate a CT-detected nodule's 2-4 year malignancy risk. This provides an additional data point for risk assessment.
No, the Lung Cancer Screening Guide does not contain advertisements. Its functionality is unlocked after a free trial with an active subscription.
